Food choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer

por Parry, BM, Lawrence, JM, Storey, L, Brown, JE, Clarke, DB, Raats, M, Horton, SM, Stilwell, JM, Rainsbury, RM
Publicado 2008

Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial

por Lester, J.E., Dodwell, D., Brown, J.E., Purohit, O.P., Gutcher, S.A., Ellis, S.P., Thorpe, R., Horsman, J.M., Coleman, R.E.
Publicado 2012

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

por Brown, J.E., Wood, S.L., Confavreux, C., Abe, M., Weilbaecher, K., Hadji, P., Johnson, R.W., Rhoades, J.A., Edwards, C.M., Croucher, P.I., Juarez, P., El Badri, S., Ariaspinilla, G., D'Oronzo, S., Guise, T.A., Van Poznak, C.
Publicado 2021

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

por Coleman, R.E., Collinson, M., Gregory, W., Marshall, H., Bell, R., Dodwell, D., Keane, M., Gil, M., Barrett-Lee, P., Ritchie, D., Bowman, A., Liversedge, V., De Boer, R.H., Passos-Coelho, J.L., O'Reilly, S., Bertelli, G., Joffe, J., Brown, J.E., Wilson, C., Tercero, J.C., Jean-Mairet, J., Gomis, R., Cameron, D.
Publicado 2018